SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022898
Filing Date
2022-08-15
Accepted
2022-08-15 16:17:49
Documents
86
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1625328
2 ex31-1.htm EX-31.1 16515
3 ex31-2.htm EX-31.2 18167
4 ex32-1.htm EX-32.1 9324
  Complete submission text file 0001493152-22-022898.txt   8262023

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qlgn-20220630.xsd EX-101.SCH 64841
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qlgn-20220630_cal.xml EX-101.CAL 74790
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qlgn-20220630_def.xml EX-101.DEF 301699
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qlgn-20220630_lab.xml EX-101.LAB 512253
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qlgn-20220630_pre.xml EX-101.PRE 428547
80 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1423614
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 221165854
SIC: 2834 Pharmaceutical Preparations